Yvonne Datta, MD

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Yvonne Datta

Contact Info

Mailing Address:
Division of Hematology, Oncology and Transplantation
420 Delaware, SE
MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Pamela Hansen

Administrative Phone
612-625-9605

Administrative Email
hanse032@umn.edu

Administrative Fax Number
612-625-6919

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation


Hematologist / Oncologist


Medical School, University of Minnesota, Minneapolis, MN

Internal Medicine Residency, Medical College of Virginia, Richmond, VA

Hematology/Oncology Fellowship, University of Michigan, Ann Arbor, MI

Fellowship, Brigham and Women's Hospital, Boston, MA

Summary

Dr. Datta received her medical degree from the University of Minnesota. She completed a residency in internal medicine at the Medical College of Virginia in Richmond, followed by a clinical fellowship in hematology/oncology at the University of Michigan, Ann Arbor. She completed additional research training in Hematology at the Brigham & Women’s Hospital, Harvard Medical School. Prior to coming to the University of Minnesota, she held faculty positions at the Medical College of Wisconsin and Emory University.

Expertise

  • Hemostasis
  • Thrombosis
  • Benign hematology
  • Hereditary hemorrhagic telangiectasia (HHT)

Awards & Recognition

  • Eta Phi Alpha
  • Commencement Address, University of Wisconsin-LaCrosse (2007)

Professional Associations

  • Member, Hematology/Oncology Fellowship Committee, University of Minnesota
  • Member, Admissions Committee, University of Minnesota
  • Director, Hematology Clinical Rotation, University of Minnesota
  • Member, Hemostasis and Thrombosis Research Society
  • Member, American Society of Hematology
  • Member, International Society of Thrombosis and Hemostasis
  • Member, American College of Physicians. 

Research

Research Summary/Interests

  • Benefits and risks of various anticoagulation agents in patients with venous thromboembolism or atrial fibrillation
  • Mechanism of pain in patients with sickle cell anemia
  • Markers of cardiovascular risk in young women on hormonal contraceptives
  • Platelet disorders

Publications

  • Khan F, Datta YH. Direct Oral Anticoagulant Use and the Incidence of Bleeding in the Very Elderly With Atrial Fibrillation. Journal of Thrombosis and Thrombolysis. In Press.
  • Kapil N, Datta YH, Alakbarova N, Selim M, Liebeskind D, Bachour O, Rao G, Divani A. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke. Clinical and Applied Thrombosis/Hemostasis. In Press.
  • Afshin A. Divani, Xianghua Luo, Datta, YH, James D. Flaherty and Angela Panoskaltsis-Mortari, Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers. Mediators of Inflammation. 2015, Mar 16. Role: Participated in developing study design, conducted literature research, manuscript preparation and editing.
  • Shah S, Larson A, Datta Y, Calciphylaxis in catastrophic antiphospholipid syndrome. Blood Coagulation & Fibrinolysis, 2015, 26, 467-8. Role: Conducted literature search, manuscript preparation and editing
  • Khan F, Datta YH. Risk of Bleeding During Long-Term Anticoagulation With Warfarin: A Tertiary Care Center Experience. Blood Coagulation & Fibrinolysis. 2015, 26, 110-2.Impact Factor: 1.248 Sum of Times Cited:Role: Developed study design, data acquisition, assisted in data analysis, manuscript editing.
  • Baumann Kreusiger LM, Datta YH, Johnson AD, Zantek ND, Shanley R, Reding MT, Monitoring Anticoagulation in Patients with an Unreliable PT/INR: Factor II versus Chromogenic Factor X Testing. Blood Coagulation & Fibrinolysis. 2014, 24, 232-6. Impact factor: 1.248 Sum of Times Cited: Role: Developed study design, data acquisition, manuscript editing.
  • Emiru T, Bershad EM, Zantek ND, Datta YH, Rao GH, Hartley EW, Divani AA. Intracerebral Hemorrhage: A Review of Coagulation Function. Clinical and Applied Thrombosis Hemostasis. 2012, 18, 652-62 Impact factor: 1.016 Sum of Times Cited: Role: Conducted literature search, manuscript preparation and editing.
  • Divani AA, Luo X, Brandy KR, Meyer RM, Joseph MS, Flaherty JD, Rao GH, Datta YH. Oral Versus Vaginal Combined Hormonal Contraceptives, Effect on Coagulation and Inflammatory Biomarkers Among Young Adult Women. Clinical and Applied Thrombosis Hemostasis. 2012, 18, 487-94. Impact factor: 1.016 Sum of Times Cited:Role: Participated in developing study design, conducted literature research, manuscript preparation and editing.
  • Brandy KR, Meyer RM, Luo X, Rao GH, Datta YH, Divani AA, Evaluation of the Coagulation Profile Among Oral and Vaginal Combined Hormonal Contraceptive Users Using Sonoclot Coagulation Analyzer. Clinical and Applied Thrombosis Hemostasis. 2012, 18, 576-81. Impact factor: 1.016 Sum of Times Cited: 1 Role: Participated in developing study design, conducted literature research, manuscript preparation and editing
  • Sohl M, Mescher M, KlappaA, Shah A, Zantek N, Datta YH. Acquired Glanzmann’s Thrombasthenia with Optimal Response to Rituximab Therapy. American Journal of Hematology. 2011, 86, 715-71. Impact factor: 4.13 Sum of Times Cited: 0 Role: Guarantor of integrity of entire study, conducted literature search, manuscript preparation and editing
  • Ninan MJ and Datta YH. Post-Transplant Lymphoproliferative Disorder Presenting As Multiple Myeloma. Am. J. Hematology. 2010, 85, 635-7. Impact factor: 4.13 Sum of Times Cited: 1 Role: Guarantor of integrity of entire study, conducted literature search, manuscript preparation and editing 
  • Zakharova MY, MeyerR, BrandyK, DattaYH, SchreinerPJ, LeeSR, Rao GH, DivaniAA. Risk Factors for Heart Attack, Stroke, and Venous Thrombosis Associated with Hormonal Contraceptive Use. Clinical and Applied Thrombosis Hemostasis. 2011, 17, 323-31. Impact factor: 1.016 Sum of Times Cited: 5 Role: conducted literature search, manuscript preparation and editing
  • Ninkovic I, White JG, Rangel-Filho A, Datta YH. The role of Rab38 in platelet dense granule defects. Journal of Thrombosis and Thrombolysis. 2008, 6, 2143-2151. Impact factor: 6.081 Sum of Times Cited: 8 Role: Guarantor of integrity of entire study, developed study concept and design, conducted literature search, manuscript preparation and editing
  • Rangel-Filho A, Sharma M, Datta YH, Moreno C, Roman RJ, Iwamoto Y, Provoost AP, Lazar J, Jacob HJ. RF-2 gene modulates proteinuria and albuminuria independently of changes in glomerular permeability in the fawn-hooded hypertensive rat. Journal of the American Society of Nephrology. 2005, 16, 852-6. Impact factor: 8.987 Sum of Times Cited: 38
  • Role: Conducted experimental studies and data acquisition, manuscript editing 
  • Cooley BC, Chen C-Y, Friedman K, Datta YH. A Prothrombotic Phenotype in the Copenhagen Rat Strain. Thrombosis Research. 2005, 115, 153-157. Impact factor: 3.133 Sum of Times Cited: 0 Role: Conducted experimental studies and data acquisition, manuscript editing
  • Datta YH, Kampalath B, Binion DG. Rituximab-induced remission of a gastric MALT lymphoma. Leukemia and Lymphoma. 2004, 45, 1297-1299. Impact factor: 2.301 Sum of Times Cited: 6 Role: Guarantor of integrity of entire study, conducted literature search, manuscript preparation and editing
  • Datta YH, Wu FC, Dumas PC, Ning G, Datta MW, Rangel-Filch A, Cooley BC, Majewski R, Provoost AP, Jacob HJ. Genetic mapping and characterization of the bleeding disorder in the fawn-hooded hypertensive rat. Thrombosis and Haemostasis. 2003, 89, 1031-1042. Impact factor: 6.094 Sum of Times Cited: 14 Role: Guarantor of integrity of entire study, developed study concept and design, conducted experimental studies and data acquisition, conducted literature search, manuscript preparation and editing 
  • Datta YH and Ewenstein BM. Regulated secretion in endothelial cells: Biology and Clinical Implications. Thrombosis and Haemostasis. 2001, 86, 1148-1155. Impact factor: 6.094 Sum of Times Cited: 29 Role: conducted literature search, manuscript preparation and editing
  • Datta YH, Youssoufian H, Marks PW, Ewenstein BM. Targeting of a heterologous protein to a regulated secretion pathway in cultured endothelial cells. Blood. 1999, 94, 2696-2703. Impact factor: 9.060 Sum of Times Cited: 23 Role: developed study concept and design, conducted experimental studies and data acquisition, conducted literature search, manuscript preparation and editing 
  • Datta YH, Romano M, Jacobson BD, Golan DE, Serhan CN, Ewenstein BM. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation. 1995, 92, 3304-11. Impact factor: 15.202 Sum of Times Cited: 78 Role: developed study concept and design, conducted experimental studies and data acquisition, conducted literature search, manuscript preparation and editing
  • Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. Journal of Clinical Oncology. 1994, 12, 475-82. Impact factor: 18.038 Sum of Times Cited: 40 Role: developed study concept and design, conducted experimental studies and data acquisition, conducted literature search, manuscript preparation and editing
  • Carr ME, Hauge Y. Enhancement of red cell washout from blood clots by alteration of gel pore size and red cell flexibility. American Journal of Physiology. 259 (5 Pt. 2), H1527-32, 1990. Impact factor: 3.629 Sum of Times Cited: 12 Role: conducted experimental studies and data acquisition

Clinical

Clinics

Center for Bleeding and Clotting Disorders;Masonic Cancer Center

Board Certifications

  • Internal Medicine
  • Hematology
  • Oncology

Clinical Interests

Bleeding and clotting disorders; Platelet disorders; Anemia; General hematology; Leukemia; Lymphoma